︎
 ︎︎︎ 3 days with >270 participants from 32 countries and 32 institutions worldwide ︎︎︎ 4 keynote talks, 13 invited speakers, 7 selected talks, and 2 poster sessions ︎︎︎ champalimaud foundation tours, a meet the expert activity, a boat trip, and a dinner party ︎︎︎ thank you!


︎    ︎    ︎    

Rafael Blanco-Domínguez, PhD


Gulbenkian Institute for Molecular Medicine – GIMM

Lisbon, Portugal

Rafael earned his PhD in 2022 at CNIC (Spain), where he identified T-cell-derived molecules for the diagnosis and therapy of acute heart diseases. As a postdoctoral researcher at GIMM, supported by EMBO and EACR–Mark Foundation fellowships, he leads research programs investigating γδ T cells in the solid tumor microenvironment and harnessing their potential for next-generation immunotherapies.